• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Orexigen Therapeutics Inc

+ Add to Watchlist


5.5000 USD 0.0400 0.72%

As of 12:30:39 ET on 04/24/2014.

Snapshot for Orexigen Therapeutics Inc (OREX)

Open: 5.6000 Day's Range: 5.3050 - 5.6000 Volume: 907,526
Previous Close: 5.5400 52wk Range: 4.5950 - 7.8400 1-Yr Rtn: -11.99%

Stock Chart for OREX

No chart data available.
  • OREX:US 5.5100
  • 1D
  • 1M
  • 1Y
Interactive OREX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OREX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 49.1150
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8000
Est. EPS (USD) (12/2014) 0.1130
Est. PEG Ratio -
Market Cap (M USD) 619.04
Shares Outstanding (M) 111.54
30 Day Average Volume 2,490,443
Price/Book (mrq) 13.8040
Price/Sale (ttm) 154.5863
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OREX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OREX

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.

Michael Narachi "Mike"President/CEOMark D BoothChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus Officer/Acting CFOHeather D TurnerSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for OREX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil